TCL Archive In Brief: Health Chief Defends Cancer Program, Corrects The Record On NCI, NIH Support Of Basic Research January 24, 1975
TCL Archive ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer June 5, 1998
TCL Archive Research community needs to be prepared for budget “flattening,” NCI director says. March 25, 2005
TCL Archive Bristol-Myers Squibb Co. has agreed to pay $450 million to settle class action suits from shareholders and separate civil claims by the Securities and Exchange Commission. The settlements stem from Bristol’s practice of building up wholesalers’ inventories and diverting operating income to enhance dividends. August 6, 2004
